EMA: Guideline on good pharmacovigilance practices (GVP) Module IX – Signal management

For the purpose of this Module, only new information related to adverse effects will be considered. In order to suggest a new potentially causal association or a new aspect of a known association, any signal should be validated taking into account other relevant sources of information

kapitał ludzki

fundusz społeczny

Narodowe Centrum Badań i Rozwoju

innowacyjna gospodarka

rozwój regionalny